Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Benefit-Risk Analysis for Decision-Making: An Approach.
Interferon β associated nephropathy in a Multiple Sclerosis patient: A case and review.
Ghrelin: A link between ageing, metabolism and neurodegenerative disorders.
Congenic mapping confirms a locus on rat chromosome 10 conferring strong protection against myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.
Human Endogenous Retrovirus and Neuroinflammation in Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
Inhibitors of urokinase type plasminogen activator and cytostatic activity from crude plants extracts.
Two novel 5-HT6 receptor antagonists ameliorate scopolamine-induced memory deficits in the object recognition and object location tasks in Wistar rats.
SLV330, a cannabinoid CB(1) receptor antagonist, attenuates ethanol and nicotine seeking and improves inhibitory response control in rats.
Dopamine characteristics in rat genotypes with distinct susceptibility to epileptic activity: apomorphine-induced stereotyped gnawing and novelty/amphetamine-induced locomotor stimulation.
Remyelination researchers regroup after proof-of-concept setback in multiple sclerosis.
Functional Brain Network Alterations in Clinically Isolated Syndrome and Multiple Sclerosis: A Graph-based Connectome Study.
Immunogenetics of multiple sclerosis: more questions than answers.
IL-3 promotes the development of experimental autoimmune encephalitis.
Acorda Therapeutics announces initiation of AMPYRA® proof-of-concept study in patients with post-stroke deficits
Association between seasonal factors and multiple sclerosis.
MicroRNA-155 contributes to shear-resistant leukocyte adhesion to human brain endothelium in vitro.
Th17 expansion in MS patients is counterbalanced by an expanded CD39+ regulatory T cell population during remission but not during relapse.
Peptide motif analysis predicts lymphocytic choriomeningitis virus as trigger for multiple sclerosis.
Deletion of 14-3-3σ sensitizes mice to DMBA/TPA-induced papillomatosis.
How Do People with Multiple Sclerosis Experience Prognostic Uncertainty and Prognosis Communication? A Qualitative Study.
Accumulation of Extracellular Matrix in Advanced Lesions of Canine Distemper Demyelinating Encephalitis.
ROCK inhibition enhances neurite outgrowth in neural stem cells by upregulating YAP expression in vitro.
Superior MRI outcomes with alemtuzumab compared with subcutaneous interferon β-1a in MS.
Multiple sclerosis activated by anti-tumor necrosis factor α (Etanercept) and the genetic risk.
Disease Activity and Conversion into Multiple Sclerosis after Optic Neuritis Is Treated with Erythropoietin.
Pages
« first
‹ previous
…
777
778
779
780
781
782
783
784
785
…
next ›
last »